The rising cost of orphan drugs

被引：0
|
作者：
不详
机构：
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E456 / E456
页数：1
相关论文
共 50 条
  • [31] The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
    Kesselheim, Aaron S.
    Myers, Jessica A.
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    Levin, Raisa
    Avorn, Jerry
    PLOS ONE, 2012, 7 (02):
  • [32] Orphan drugs and orphan tests in the USA
    Thoene, JG
    COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
  • [33] Thiamine shortage - Plight of low-cost, lifesaving orphan drugs
    Kumar, PD
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05): : 532 - 533
  • [34] The rising cost of glaucoma drugs in Ireland 1996-2003
    Knox, FA
    Barry, M
    McGowan, B
    O'Brien, C
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (02) : 162 - 165
  • [35] Cost-Effectiveness Assessment of Orphan Drugs A Scientific and Political Conundrum
    Simoens, Steven
    Picavet, Eline
    Dooms, Marc
    Cassiman, David
    Morel, Thomas
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (01) : 1 - 3
  • [36] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
    Makoto Shiragami
    Kiyohito Nakai
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
  • [37] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
    Shiragami, M
    Nakai, K
    DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
  • [38] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
    Ounsirithupsakul, T.
    Samphansompoch, T.
    Sermsakulthai, T.
    Taychakhoonavudh, S.
    VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [39] ORPHAN DISEASES AND ORPHAN DRUGS - SCHEINBERG, WALSHE
    QURESHI, B
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1987, 107 (04): : 160 - 160
  • [40] Orphan drugs for myelofibrosis
    Harrison, Claire N.
    Bennett, Michael
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 391 - 405
12345